首页|difelikefalin治疗血液透析相关皮肤瘙痒的研究进展

difelikefalin治疗血液透析相关皮肤瘙痒的研究进展

扫码查看
血液透析患者的常见并发症之一即皮肤瘙痒,不仅影响患者的身心健康、增加死亡风险,也为患者家庭、医护人员及社会带来了巨大负担。瘙痒的发病机制有多种假说存在,但目前仍未有定论,针对该并发症的治疗也缺少针对性策略。文章主要就FDA新近批准药物difelikefalin治疗血液透析相关皮肤瘙痒的生理机制、治疗进展等作一综述。
Progress of Difelikefalin in the Treatment of Hemodialysis Pruritus
One of the common complications of hemodialysis patients was pruritus,not only affected the physical and mental health of the patients and increased the risk of mortality,but also imposed a significant burden on patients'families,healthcare providers,and society.Various hypotheses regarding the pathogenesis of pruritus existed,but the jury was still out.There was also a lack of targeted strategies for the treatment of this complication.The physiological mechanism and progress of difelikefalinof FDA recently approved the drug in the treatment of hemodialysis-related pruritus were reviewed in this article.

Chronic kidney disease-associated pruritusDifelikefalinKidney dialysisPharmacotherapy

韩清霞、杜静、赵战云

展开 >

山东第二医科大学,山东潍坊 261000

潍坊市人民医院肾脏病医学中心,山东潍坊 261000

慢性肾脏病相关性瘙痒症 地非法林 肾透析 药物治疗

2024

药物生物技术
中国药科大学,中国医药科技出版社,中国药学会

药物生物技术

CSTPCD
影响因子:0.463
ISSN:1005-8915
年,卷(期):2024.31(4)